Amanda Hansen-Kvist

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Baseline monocytes ≥ 925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.

Baseline monocytes ≥ 925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.

Journal: Journal of the American Academy of Dermatology

Published: November 21, 2025

Drug Stratification Based on Real-World Evidence in Psoriasis: A Narrative Review.

Drug Stratification Based on Real-World Evidence in Psoriasis: A Narrative Review.

Journal: Dermatology and therapy

Published: September 30, 2025

Dysbiosis of the Saliva Microbiota in Patients with Psoriasis: A Case-Control Study.

Dysbiosis of the Saliva Microbiota in Patients with Psoriasis: A Case-Control Study.

Journal: Journal of inflammation research

Published: August 05, 2025

Psoriasis: Considerations for the Management of Women of Childbearing Potential.

Psoriasis: Considerations for the Management of Women of Childbearing Potential.

Journal: American journal of clinical dermatology

Published: July 31, 2025

Title Not Found

Title Not Found

Journal: Ugeskrift for laeger

Published: November 22, 2024

Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100 000 individuals.

Low-grade systemic inflammation is associated with risk of psoriasis in a general population study of more than 100 000 individuals.

Journal: The British journal of dermatology

Published: August 20, 2024

Humoral immunity after a booster dose of COVID-19 vaccine in patients with psoriasis treated with methotrexate and biologics: a cohort study.

Humoral immunity after a booster dose of COVID-19 vaccine in patients with psoriasis treated with methotrexate and biologics: a cohort study.

Journal: Clinical and experimental dermatology

Published: April 29, 2024

Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies.

Does Systemic Anti-Psoriatic Treatment Impact the Risk of Cardiovascular Disease? A Review Over Cardiovascular Imaging Studies.

Journal: Dermatology and therapy

Published: October 15, 2023

Characterization of circulating extracellular traps and immune responses to citrullinated LL37 in psoriasis.

Characterization of circulating extracellular traps and immune responses to citrullinated LL37 in psoriasis.

Journal: Frontiers in immunology

Published: June 26, 2023

Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis.

Blood Cell Biomarkers of Inflammation and Cytokine Levels as Predictors of Response to Biologics in Patients with Psoriasis.

Journal: International journal of molecular sciences

Published: February 20, 2023

Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort study.

Waning humoral and cellular immunity after COVID-19 vaccination in patients with psoriasis treated with methotrexate and biologics: a cohort study.

Journal: The British journal of dermatology

Published: October 26, 2022

Neutrophil-to-lymphocyte ratio and the systemic immune-inflammation index as potential biomarkers of effective treatment and subclinical atherosclerotic cardiovascular disease in patients with psoriasis.

Neutrophil-to-lymphocyte ratio and the systemic immune-inflammation index as potential biomarkers of effective treatment and subclinical atherosclerotic cardiovascular disease in patients with psoriasis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: March 09, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026